Key Quantitative Figures
- Total Rights Equity Shares allotted: 83,64,036 shares of face value ₹10 each
- Fully paid shares: 75,03,333 shares at ₹15 per share (including premium of ₹5)
- Partly paid shares: 8,60,703 shares at ₹3.75 paid on application (including premium of ₹1.25)
- Previous paid-up equity share capital: ₹45,53,62,560 comprising 4,55,36,256 fully paid-up equity shares
- New paid-up equity share capital: ₹53,25,47,648 comprising 5,30,39,589 fully paid-up equity shares and 8,60,703 partly paid-up (₹2.50 paid-up) equity shares
Dates of Action
- Rights Issue Committee meeting: November 03, 2026 (commenced at 4:30 PM, concluded at 5:30 PM)
- BSE Limited approval email: November 02, 2026
Parties Involved
- Rights Issue Committee of Indrayani Biotech Limited
- Designated Stock Exchange: BSE Limited
- Committee Chairman: Nangavaram Mahadevan Ranganathan (DIN: 06377402)
Capital Structure Impact
The rights issue allotment has resulted in:
- Increase in total number of equity shares from 4,55,36,256 to 5,38,00,292 (including partly paid shares)
- Increase in paid-up equity capital from ₹45,53,62,560 to ₹53,25,47,648
- Creation of 8,60,703 partly paid-up equity shares with ₹2.50 paid-up per share
Additional Details from Annexure A
- Type of securities: Partly paid-up equity shares
- Type of issuance: Rights issue to eligible equity shareholders as on record date
- Issue price: ₹15 per equity share (including premium of ₹5 per equity share)
- Balance amount for partly paid shares shall be payable on next call as defined in the Letter of Offer
- No cancellation or termination of proposal for issuance of securities
Financial Impact
The rights issue has resulted in immediate capital infusion through:
- Full payment received for 75,03,333 shares at ₹15 each (total ₹11,25,49,995)
- Partial payment received for 8,60,703 shares at ₹3.75 each (total ₹3,22,76,36.25)
- Total immediate capital raised: approximately ₹14,48,26,331.25
- Additional capital to be received on future calls for partly paid shares